首站-论文投稿智能助手
典型文献
UPF1 increases amino acid levels and promotes cell proliferation in lung adenocarcinoma via the eIF2α-ATF4 axis
文献摘要:
Up-frameshift 1 (UPF1), as the most critical factor in nonsense-mediated messenger RNA (mRNA) decay (NMD), regulates tumor-associated molecular pathways in many cancers. However, the role of UPF1 in lung adenocarcinoma (LUAD) amino acid metabolism remains largely unknown. In this study, we found that UPF1 was significantly correlated with a portion of amino acid metabolic pathways in LUAD by integrating bioinformatics and metabolomics. We further confirmed that UPF1 knockdown inhibited activating transcription factor 4 (ATF4) and Ser51 phosphorylation of eukaryotic translation initiation factor 2α(eIF2α), the core proteins in amino acid metabolism reprogramming. In addition, UPF1 promotes cell proliferation by increasing the amino-acid levels of LUAD cells, which depends on the function of ATF4. Clinically, UPF1 mRNA expression is abnormal in LUAD tissues, and higher expression of UPF1 and ATF4 was significantly correlated with poor overall survival (OS) in LUAD patients. Our findings reveal that UPF1 is a potential regulator of tumor-associated amino acid metabolism and may be a therapeutic target for LUAD.
文献关键词:
作者姓名:
Lei FANG;Huan QI;Peng WANG;Shiqing WANG;Tianjiao LI;Tian XIA;Hailong PIAO;Chundong GU
作者机构:
Department of Thoracic Surgery,Lung Cancer Diagnosis and Treatment Center of Dalian,The First Affiliated Hospital of Dalian Medical University,Dalian 116011,China;CAS Key Laboratory of Separation Science for Analytical Chemistry,Dalian Institute of Chemical Physics,Chinese Academy of Sciences,Dalian 116023,China
引用格式:
[1]Lei FANG;Huan QI;Peng WANG;Shiqing WANG;Tianjiao LI;Tian XIA;Hailong PIAO;Chundong GU-.UPF1 increases amino acid levels and promotes cell proliferation in lung adenocarcinoma via the eIF2α-ATF4 axis)[J].浙江大学学报(英文版)(B辑:生物医学和生物技术),2022(10):863-875
A类:
Ser51
B类:
UPF1,increases,amino,acid,levels,promotes,proliferation,lung,adenocarcinoma,via,eIF2,ATF4,axis,Up,frameshift,most,critical,nonsense,mediated,messenger,decay,NMD,regulates,tumor,associated,molecular,pathways,many,cancers,However,role,LUAD,metabolism,remains,largely,unknown,In,this,study,found,that,was,significantly,correlated,portion,metabolic,by,integrating,bioinformatics,metabolomics,We,further,confirmed,knockdown,inhibited,activating,transcription,phosphorylation,eukaryotic,translation,initiation,core,proteins,reprogramming,addition,increasing,cells,which,depends,function,Clinically,expression,abnormal,tissues,higher,poor,overall,survival,OS,patients,Our,findings,reveal,potential,regulator,may,be,therapeutic,target
AB值:
0.547342
相似文献
Paired box 5 increases the chemosensitivity of esophageal squamous cell cancer cells by promoting p53 signaling activity
Zhang Weiwei;Yan Wenji;Qian Niansong;Han Quanli;Zhang Weitao;Dai Guanghai-Chinese People’s Liberation Army Medical School, Beijing 100853, China;Department of the Third Health Care, The Second Medical Center, Chinese People’s Liberation Army General Hospital, Beijing 100853, China;Department of Oncology, The First Medical Center, Chinese People’s Liberation Army General Hospital, Beijing 100853, China;Department of Oncology, The Hainan Medical Center, Chinese People’s Liberation Army General Hospital, Sanya 572022, China;Cancer Center, Beijing Tongren Hospital Affiliated to Capital Medical University, Economic and Technological Development Zone, Beijing 100176, China
NAT10 promotes cell proliferation by acetylating CEP170 mRNA to enhance translation efficiency in multiple myeloma
Rongfang Wei;Xing Cui;Jie Min;Zigen Lin;Yanyan Zhou;Mengjie Guo;Xiaojuan An;Hao Liu;Siegfried Janz;Chunyan Gu;Hongbo Wang;Ye Yang-Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine,Nanjing 210022,China;School of Medicine&Holistic Integrative Medicine,Nanjing University of Chinese Medicine,Nanjing 210023,China;Department of Hematology,Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan 250014,China;Division of Hematology and Oncology,Medical College of Wisconsin,Milwaukee,WI 53226,USA;School of Pharmacy,Key Laboratory of Molecular Pharmacology and Drug Evaluation(Yantai University),Ministry of Education,Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong,Yantai University,Yantai 264005,China;Bohai Rim Advanced Research Institute for Drug Discovery,Yantai 264003,China
Stratifin promotes renal dysfunction in ischemic and nephrotoxic AKI mouse models via enhancing RIPK3-mediated necroptosis
Fang Wang;Jia-nan Wang;Xiao-yan He;Xiao-guo Suo;Chao Li;Wei-jian Ni;Yu-ting Cai;Yuan He;Xin-yun Fang;Yu-hang Dong;Tian Xing;Ya-ru Yang;Feng Zhang;Xiang Zhong;Hong-mei Zang;Ming-ming Liu;Jun Li;Xiao-ming Meng;Juan Jin-Inflammation and Immune Mediated Diseases Laboratory of Anhui Province,Anhui Institute of Innovative Drugs,School of Pharmacy,Anhui Medical University,The Key Laboratory of Anti-inflammatory of Immune Medicines,Ministry of Education,Hefei 230032,China;Department of Pharmacy,Anhui Provincial Hospital,The First Affiliated Hospital of USTC,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei 230001,China;Hospital of Stomatology,Anhui Medical University,Key Laboratory of Oral Diseases Research of Anhui Province,Hefei 230032,China;Department of Pharmacy,Changzheng Hospital,Naval Medical University,Shanghai 200003,China;Department of Nephrology,Sichuan Academy of Medical Sciences&Sichuan Provincial People's Hospital,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610072,China;School of Basic Medical Sciences,Anhui Medical University,Hefei 230032,China
KCNN4-mediated Ca2+/MET/AKT axis is promising for targeted therapy of pancreatic ductal adenocarcinoma
Xiao Mo;Cheng-fei Zhang;Ping Xu;Min Ding;Zhi-jie Ma;Qi Sun;Yu Liu;Hong-kai Bi;Xin Guo;Alaa Abdelatty;Chao Hu;Hao-jun Xu;Guo-ren Zhou;Yu-liang Jia;Hong-ping Xia-Sir Run Run Hospital,Nanjing Medical University,Nanjing 211166,China;School of Basic Medical Sciences&State Key Laboratory of Reproductive Medicine&Key Laboratory of Antibody Technique of National Health Commission&Jiangsu Antibody Drug Engineering Research Center,Nanjing Medical University,Nanjing 210092,China;Jiangsu Cancer Hospital&Jiangsu Institute of Cancer Research&The Affiliated Cancer Hospital of Nanjing Medical University,Nanjing 210092,China;Yijishan Hospital of Wannan Medical College,Wannan Medical College,Wuhu 241002,China
Intrarenal 1-methoxypyrene,an aryl hydrocarbon receptor agonist,mediates progressive tubulointerstitial fibrosis in mice
Gang Cao;Hua Miao;Yan-ni Wang;Dan-qian Chen;Xia-qing Wu;Lin Chen;Yan Guo;Liang Zou;Nosratola D.Vaziri;Ping Li;Ying-yong Zhao-School of Pharmacy,Zhejiang Chinese Medical University,No.548 Binwen Road,Hangzhou 310053,China;Faculty of Life Science&Medicine,Northwest University,No.229 Taibai North Road,Xi'an 710069,China;Beijing Key Lab for Immune-Mediated Inflammatory Diseases,Institute of Clinical Medical Science,Department of Nephrology,China-Japan Friendship Hospital,No.2 Yinghua East Road,Beijing 100029,China;Department of Internal Medicine,University of New Mexico,1700 Lomas Blvd NE,Albuquerque,NM 87131,USA;School of Food and Bioengineering,Chengdu University,No.2025 Chengluo Avenue,Chengdu 610106,China;Division of Nephrology and Hypertension,School of Medicine,University of California Irvine,1001 Health Sciences Rd,Irvine,CA 92897,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。